Donor Stem Cell Transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor Stem Cell Transplantation, covering 2017-03-16 to 2017-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies [Phase 2]